American Society of Hematology: Undergoing Stem Cell Transplant for Sickle Cell Disease in Childhood Improves Quality of Life a Decade Later
December 11, 2024
December 11, 2024
WASHINGTON, Dec. 11 (TNSres) -- The American Society of Hematology issued the following news release:
* * *
Transplant recipients show better physical, school, and social functioning than those receiving transfusions and medications alone
LBA-5: Outcome of Cerebral Vasculopathy and Cognitive Performances 10 Years Post-Enrollment in the Drepagreffe Trial Comparing Allogeneic Stem Cell Transplantation to Standard-Care in Children with Sickle Cell Anemia and H . . .
* * *
Transplant recipients show better physical, school, and social functioning than those receiving transfusions and medications alone
LBA-5: Outcome of Cerebral Vasculopathy and Cognitive Performances 10 Years Post-Enrollment in the Drepagreffe Trial Comparing Allogeneic Stem Cell Transplantation to Standard-Care in Children with Sickle Cell Anemia and H . . .